8-K: Atlantic Coastal Acquisition Corp. II Faces Delisting Notice Despite Business Combination Progress

Atlantic Coastal Acquisition Corp. II received a delisting notice from Nasdaq for failing to meet listing requirements, but plans to appeal and expects to regain compliance upon closing its business combination with Abpro Corporation.

Summary

• Atlantic Coastal Acquisition Corp. II (ACAB) received a delisting notice from Nasdaq for failing to meet minimum market value and holder requirements.
• ACAB failed to maintain a minimum market value of publicly held shares of $15,000,000 for 30 consecutive trading days.
• The company also failed to maintain a minimum of 400 unrestricted round lot holders and 750,000 publicly held shares.
• ACAB was granted a compliance period until October 15, 2024, which it failed to meet.
• The company intends to request a hearing before a Nasdaq Hearing Panel by October 23, 2024, which will temporarily stay the delisting.
• ACAB expects to regain compliance upon the closing of its business combination with Abpro Corporation.
• The company has extended the deadline to complete the business combination from October 19, 2024, to November 19, 2024.
• The Registration Statement for the business combination went effective on October 18, 2024.

Sentiment

Score: 3

Explanation: The document contains negative news regarding a delisting notice, but there is a potential positive outcome with the business combination. The overall sentiment is negative due to the delisting risk.

Positives

• ACAB intends to request a hearing to appeal the delisting notice, which will temporarily stay the delisting.
• The company expects to regain compliance with Nasdaq listing rules upon the closing of the business combination with Abpro.
• The Registration Statement for the business combination has gone effective, indicating progress towards the merger.
• The deadline for completing the business combination has been extended, providing more time to finalize the deal.

Negatives

• ACAB received a delisting notice from Nasdaq for failing to meet listing requirements.
• The company failed to maintain the minimum market value of publicly held shares and the minimum number of holders.
• The company failed to meet the compliance deadline of October 15, 2024, to cure the Nasdaq deficiencies.

Risks

• There is a risk that the Nasdaq Hearing Panel may not grant an extension or reverse the delisting decision.
• The business combination with Abpro may not close, which would prevent ACAB from regaining compliance with Nasdaq listing rules.
• The company faces risks related to the rollout of Abpro's business and the timing of expected business milestones.
• There are risks associated with the integration of ACAB and Abpro's businesses.
• The amount of redemption requests made by ACAB's stockholders could impact the success of the business combination.
• The company is subject to general economic, financial, legal, political and business conditions and changes in domestic and foreign markets.

Future Outlook

ACAB expects to regain compliance with Nasdaq listing rules upon the closing of the business combination with Abpro. The company has extended the deadline to complete the business combination to November 19, 2024.

Management Comments

• The Company expected, and still expects, the Nasdaq Deficiencies to be cured as a result of its previously announced proposed business combination with Abpro Corporation.
• We expect that we will regain compliance with each of the foregoing Nasdaq listing rules upon the closing of the Business Combination.

Industry Context

The delisting notice highlights the challenges faced by SPACs in maintaining listing requirements, especially when facing delays in completing business combinations. This situation is not uncommon in the current market environment where many SPACs are struggling to find suitable merger targets and meet listing criteria.

Comparison to Industry Standards

• Many SPACs have faced similar challenges in maintaining listing compliance, particularly those that have not completed a business combination within the required timeframe.
• The minimum market value and holder requirements are standard for Nasdaq listings, and failure to meet these is a common reason for delisting notices.
• Other SPACs such as those that have failed to complete a business combination within the required timeframe have also faced delisting notices.
• The extension of the business combination deadline is a common strategy used by SPACs to buy more time to complete a deal.

Stakeholder Impact

• Shareholders face the risk of delisting and potential loss of investment if the business combination is not completed.
• Employees may experience uncertainty due to the potential delisting and business combination.
• Customers and suppliers of both ACAB and Abpro may be impacted by the uncertainty surrounding the business combination.

Next Steps

• ACAB will request a hearing before a Nasdaq Hearing Panel by October 23, 2024.
• The company will continue to work towards closing the business combination with Abpro by November 19, 2024.

Key Dates

Keywords

delisting, Nasdaq, business combination, Abpro, listing requirements, market value, shareholders, merger, compliance, hearing